首页 > 市场调查报告书 > 製药

全球大麻素市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测

市场调查报告书

商品编码

1342892

全球大麻素市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测

Global Cannabinoids Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年08月01日 | 出版商:

Value Market Research | 英文 242 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球大麻素市场需求预计将从 2022 年的 255.4 亿美元增至 2030 年近 1964 亿美元，2023-2030 年研究期间复合年增长率为 25.44%。

大麻素，也称为医用大麻，可以治疗疾病或改善其症状。它们用于控制疼痛、血压、记忆力、注意力、食慾、感官刺激、肌肉问题和癫痫发作以及其他疾病或健康状况。该材料还用于身体护理领域，作为身体油、乳液和胶囊的成分。

市场动态：

近年来，使用大麻治疗各种医疗疾病在全国越来越受欢迎。市场扩张的推动因素包括客户对含有大麻素的产品的偏好不断提高以及公众对大麻及相关产品的认识不断提高。政府对大麻素的有利政策也吸引了更多公司进入该行业。此外，有前景的研究表明次要和主要大麻素在治疗各种健康问题方面的益处，提高了公众对大麻使用的认识。然而，预计生产和提取的高成本，特别是小大麻素的成本，将阻碍市场扩张。

该报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球大麻素市场的每个细分市场进行了包容性评估。大麻素行业的增长和趋势为本研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲大麻素市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。大麻素市场的主要参与者包括 Mylan NV (Viatris Inc.)、Alkem Labs、GW Pharmaceuticals plc、Tilray Inc.、Aurora Cannabis Inc.、Canopy Growth Corporation 和 The Cronos Group。本节包含竞争格局的整体视图，包括各种战略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何定制要求，请写信给我们。我们的研究团队可以根据您的需求提供定制报告。

区域展望
介绍
北美销售分析
- 概览、历史和预测数据销售分析
- 北美按细分市场销售分析
- 北美按国家/地区销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史和预测数据销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家/地区销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 意大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史和预测数据销售分析
- 亚太地区按细分市场销售分析
- 亚太地区国家/地区销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳大利亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史和预测数据销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家/地区销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史和预测数据销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲国家销售分析
- 沙特阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 10 章：大麻素公司的竞争格局

大麻素市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 11 章：公司简介

公司股份分析
市场集中度
Mylan NV (Viatris Inc.)

公司简介
公司收入
产品
最近的发展

Alkem Labs

公司简介
公司收入
产品
最近的发展

GW Pharmaceuticals plc

公司简介
公司收入
产品
最近的发展

Tilray Inc.

公司简介
公司收入
产品
最近的发展

Aurora Cannabis Inc.

公司简介
公司收入
产品
最近的发展

Canopy Growth Corporation

公司简介
公司收入
产品
最近的发展

The Cronos Group

公司简介
公司收入
产品
最近的发展

注意 - 在公司概况中，财务详细信息和近期发展视情况而定，或者如果是私营公司，则可能不包括在内

简介目录图表

Product Code: VMR11219442

The global demand for Cannabinoids Market is presumed to reach the market size of nearly USD 196.4 BN by 2030 from USD 25.54 BN in 2022 with a CAGR of 25.44% under the study period of 2023 - 2030.

Cannabinoids, also known as medical marijuana, treat diseases or improve their symptoms. They are employed in the control of pain, blood pressure, memory, focus, appetite, sensory stimulation, muscular issues, and seizures, among other disorders or health situations. The material is additionally employed in the body care sector as a component of body oils, lotions, and capsules.

MARKET DYNAMICS:

In recent years, the use of cannabis for various medical ailments has gained popularity in the nation. Market expansion is fueled by elements including rising customer preference for products containing cannabinoids and increasing public awareness of cannabis and related products. Favourable government policies around cannabinoids have also attracted more companies to the industry. Additionally, promising research suggesting the benefits of minor and major cannabinoids in treating various health issues has raised public awareness of cannabis use. However, it is anticipated that the high costs of production and extraction, particularly for small cannabinoids, will impede market expansion.

The report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cannabinoids. The growth and trends of Cannabinoids Industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the cannabinoids market report provides detailed data on the segments by analyzing them at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Cannabidiol
Tetrahydrocannabinol
Cannabinol
Others

By Application

Medicinal Use (Chronic Pain, Neurological Disorders Management, Oncology, Others)
Non-Medical Use

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Stores

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Cannabinoids market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cannabinoids market include Mylan N.V. (Viatris Inc.), Alkem Labs, GW Pharmaceuticals plc, Tilray Inc., Aurora Cannabis Inc., Canopy Growth Corporation, The Cronos Group. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . CANNABINOIDS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Distribution Channel
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL CANNABINOIDS MARKET ANALYSIS BY PRODUCT TYPE

6.1 Overview by Product Type
6.2 Historical and Forecast Data
6.3 Analysis by Product Type
6.4 Cannabidiol Historic and Forecast Sales by Regions
6.5 Tetrahydrocannabinol Historic and Forecast Sales by Regions
6.6 Cannabinol Historic and Forecast Sales by Regions
6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL CANNABINOIDS MARKET ANALYSIS BY APPLICATION

7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Medicinal Use (Chronic Pain, Neurological Disorders Management, Oncology, Others) Historic and Forecast Sales by Regions
7.5 Non-medical Use Historic and Forecast Sales by Regions

8 . GLOBAL CANNABINOIDS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

8.1 Overview by Distribution Channel
8.2 Historical and Forecast Data
8.3 Analysis by Distribution Channel
8.4 Hospital Pharmacies Historic and Forecast Sales by Regions
8.5 Retail Pharmacies Historic and Forecast Sales by Regions
8.6 Online Stores Historic and Forecast Sales by Regions

9 . GLOBAL CANNABINOIDS MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Data Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Data Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Data Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Data Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Data Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE CANNABINOIDS COMPANIES

10.1. Cannabinoids Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF CANNABINOIDS INDUSTRY

11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. Mylan N.V. (Viatris Inc.)
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Alkem Labs
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. GW Pharmaceuticals plc
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Tilray Inc.
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Aurora Cannabis Inc.
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Canopy Growth Corporation
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. The Cronos Group
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers : Impact Analysis
Restraints : Impact Analysis
List of Raw Material
List of Raw Material Manufactures
List of Potential Buyers
Analysis by Product Type (Tons and USD MN)
Cannabidiol Market Sales by Geography (Tons and USD MN)
Tetrahydrocannabinol Market Sales by Geography (Tons and USD MN)
Cannabinol Market Sales by Geography (Tons and USD MN)
Others Market Sales by Geography (Tons and USD MN)
Analysis Market by Application (Tons and USD MN)
Medicinal Use (Chronic Pain, Neurological Disorders Management, Oncology, Others) Market Sales by Geography (Tons and USD MN)
Non-medical Use Market Sales by Geography (Tons and USD MN)
Analysis by Distribution Channel (Tons and USD MN)
Hospital Pharmacies Market Sales by Geography (Tons and USD MN)
Retail Pharmacies Market Sales by Geography (Tons and USD MN)
Online Stores Market Sales by Geography (Tons and USD MN)
Global Cannabinoids Market Sales by Geography (Tons and USD MN)
North America Market Analysis (Tons and USD MN)
United State Market Analysis (Tons and USD MN)
Canada Market Analysis (Tons and USD MN)
Mexico Market Analysis (Tons and USD MN)
Europe Market Analysis (Tons and USD MN)
Europe Market Estimate by Country (Tons and USD MN)
United Kingdom Market Analysis (Tons and USD MN)
France Market Analysis (Tons and USD MN)
Germany Market Analysis (Tons and USD MN)
Italy Market Analysis (Tons and USD MN)
Russia Market Analysis (Tons and USD MN)
Spain Market Analysis (Tons and USD MN)
Rest of Europe Market Analysis (Tons and USD MN)
Asia Pacific Market Analysis (Tons and USD MN)
China Market Analysis (Tons and USD MN)
Japan Market Analysis (Tons and USD MN)
India Market Analysis (Tons and USD MN)
South Korea Market Analysis (Tons and USD MN)
Australia Market Analysis (Tons and USD MN)
Rest of Asia Pacific Market Analysis (Tons and USD MN)
Latin America Market Analysis (Tons and USD MN)
Brazil Market Analysis (Tons and USD MN)
Argentina Market Analysis (Tons and USD MN)
Peru Market Analysis (Tons and USD MN)
Chile Market Analysis (Tons and USD MN)
Rest of Latin America Market Analysis (Tons and USD MN)
Middle East & Africa Market Analysis (Tons and USD MN)
Saudi Arabia Market Analysis (Tons and USD MN)
UAE Market Analysis (Tons and USD MN)
Israel Market Analysis (Tons and USD MN)
South Africa Market Analysis (Tons and USD MN)
Rest of Middle East and Africa Market Analysis (Tons and USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Cannabinoids Report
Market Research Process
Market Research Methodology
Global Cannabinoids Market Size, by Region (Tons and USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Product Type
Market Attractiveness Analysis by Application
Market Attractiveness Analysis by Distribution Channel
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Market Analysis by Product Type (Tons and USD MN)
Cannabidiol Market Sales by Geography (Tons and USD MN)
Tetrahydrocannabinol Market Sales by Geography (Tons and USD MN)
Cannabinol Market Sales by Geography (Tons and USD MN)
Others Market Sales by Geography (Tons and USD MN)
Global Market Analysis by Application (Tons and USD MN)
Medicinal Use (Chronic Pain, Neurological Disorders Management, Oncology, Others) Market Sales by Geography (Tons and USD MN)
Non-medical Use Market Sales by Geography (Tons and USD MN)
Global Market Analysis by Distribution Channel (Tons and USD MN)
Hospital Pharmacies Market Sales by Geography (Tons and USD MN)
Retail Pharmacies Market Sales by Geography (Tons and USD MN)
Online Stores Market Sales by Geography (Tons and USD MN)
Global Market Sales (Tons and USD MN)
North America Market Sales (Tons and USD MN)
Europe Market Sales (Tons and USD MN)
Asia Pacific Market Sales (Tons and USD MN)
Latin America Market Sales (Tons and USD MN)
Middle East & Africa Market Sales (Tons and USD MN)
Recent Development in Industry
Top Company Market Share Analysis